LUGPA Series
LUGPA Virtual Crossfire Discussion and Debate Series
Presentations
nmCRPC Updates: Focus on QoL and AE data updates
Speakers: Sukumar Ethirajan, Medical DirectorNeal D. Shore, MD, FACS, Medical Director, CPIAaron Berger, MD, Vice President and Director of Advanced Prostate Cancer Duration: 60 minutes
Presented on: March 5, 2021
*This session is not eligible for AMA PRA Category 1 CreditsTM
Genomic Profiling to Aid Therapy Selection for Metastatic Prostate Cancer Patients
Speakers: Gautam Jayram, MD, Co-director, Advanced Therapeutic Center Duration: 60 minutes
Presented on: March 23, 2021
*This session is not eligible for AMA PRA Category 1 CreditsTM
A case-based discussion: Use of genomic testing in patients with favorable and unfavorable intermediate risk prostate cancer
Speakers: Steven Canfield, MD, Chief of UrologyNeal D. Shore, MD, FACS, Medical Director, CPI Duration: 60 minutes
Presented on: April 14, 2021
*This session is not eligible for AMA PRA Category 1 CreditsTM
Advanced Prostate Cancer: Incorporating Genomic Profiling and Biomarker Testing in Clinical Practice
Speakers: Scott Sellinger, MD, FACS, President, Advanced Urology InstituteNeal D. Shore, MD, FACS, Medical Director, CPI Duration: 60 minutes
Presented on: July 27, 2021
*This session is not eligible for AMA PRA Category 1 CreditsTM
A case-based discussion: Genomic testing for increased confidence in management of localized prostate cancer
Speakers: Andrew Stephenson, MD, Section Chief and Director, Urologic OncologySoroush Rais-Bahrami, MD, Associate Professor, Urology and RadiologyNeal D. Shore, MD, FACS, Medical Director, CPI Duration: 60 minutes
Presented on: October 1, 2021
*This session is not eligible for AMA PRA Category 1 CreditsTM
Private Equity (PE): Fad or Future?
Speakers: Deepak Kapoor, MD, Market PresidentScot Davis, CEOJonathan Henderson, MD, CEONeal D. Shore, MD, FACS, Medical Director, CPI Duration: 60 minutes
Presented on: December 9, 2020
*This session is not eligible for AMA PRA Category 1 CreditsTM
Speakers
Sukumar Ethirajan
Sukumar Ethirajan
Medical Director
Sukumar Ethirajan, MD, has over 25 years of clinical and scientific experience and has co-authored numerous scientific publications. He founded Dr.E.T.’s Concierge Care, LLC in Overland Park, Kansas and serves on multiple boards, including the Center for Practical Bioethics and the NCCN State Oncology Society Forum. Dr Ethirajan earned his MBBS (medical) degree at the University of Madras – Stanley Medical College in India and completed post-graduate training at Boston University, Harvard University, University of California – Los Angeles, and University of Minnesota.Neal D. Shore, MD, FACS
Neal D. Shore, MD, FACS
Medical Director, CPI
Neal D. Shore, MD, FACS, is the medical director for the Carolina Urologic Research Center and practices with Atlantic Urology Clinics in Myrtle Beach, South Carolina. Dr Shore has conducted more than 350 clinical trials that focus mainly on GU oncology, has served on the executive boards of the Society of Urologic Oncology, Bladder Cancer Advocacy Network and the Society of Urologic Oncology Clinical Trials Consortium, and is immediate past president of the Large Urology Group Practice Association. He is a founder for the CUSP Clinical Trials Consortium and DASHKO, large urology practices data registries. He has over 150 peer-reviewed publications, several book chapters, and is a peer reviewer for numerous high-impact medical journals. He earned his MD from Duke University Medical School and general surgery/urology residency at New York Hospital-Cornell and Memorial Sloan Kettering Cancer Center.Session Appearances
Second-line Therapy and Beyond for Progressive UC
Redefining the ‘Best’ Treatment Option for Patients with UTUC
Refining the First-Line and Maintenance Therapy Approach for Advanced/Metastatic UC
Advanced Prostate Cancer: Incorporating Genomic Profiling and Biomarker Testing in Clinical Practice
A Stratified Approach to Managing NMIBC with Surgical vs Non-Surgical Options
Aaron Berger, MD
Aaron Berger, MD
Vice President and Director of Advanced Prostate Cancer
Aaron D. Berger, MD, is vice president and director of Advanced Prostate Cancer with Associated Urological Specialists in the Southwest suburbs of Chicago. He earned his Bachelor of Science degree at the University of Wisconsin – Madison and attended medical school at the David Geffen School of Medicine at the University of California – Los Angeles. Dr Berger went on to complete his residency in Urology at New York University’s Langone Medical Center and his fellowship at the University of California – San Francisco.
Gautam Jayram, MD
Gautam Jayram, MD
Co-director, Advanced Therapeutic Center
Gautam Jayram, MD, is a urologist and partner with Urology Associates, P.C. in Nashville, Tennessee. As co-director of the Advanced Therapeutic Center at Urology Associates, P.C, he focuses on caring for patients with advanced urologic cancers and helps direct an active clinical trials program that serves a wide geographic area in the Southeast. Dr Jayram has served in several advisory and leadership roles and currently sits on the LUGPA Education Committee. He is passionate about integrating novel technologies and therapeutics in community urology and promoting high-value care in independent group practice. Dr Jayram received his medical degree from Vanderbilt University in Nashville and completed his urology residency at the University of Chicago Hospitals in Illinois.
Steven Canfield, MD
Steven Canfield, MD
Chief of Urology
Scott Sellinger, MD, FACS
Scott Sellinger, MD, FACS
President, Advanced Urology Institute
Scott Sellinger, MD, FACS, is president of the Advanced Urology Institute (AUI) in Tallahassee, Florida, chairs the Advanced Prostate Cancer (APC) Committee, and oversees seven APC clinics within AUI. In addition, he has served on the board of directors for the Large Urology Group Practice Association (LUGPA) for the past six years. Dr Sellinger has developed a special interest in risk management and prevention of medical errors and has lectured extensively on these subjects during the past several years. He is also interested in large group practice development and management.
Andrew Stephenson, MD
Andrew Stephenson, MD
Section Chief and Director, Urologic Oncology
Soroush Rais-Bahrami, MD
Soroush Rais-Bahrami, MD
Associate Professor, Urology and Radiology
Deepak Kapoor, MD
Scot Davis
Jonathan Henderson, MD
Jonathan Henderson, MD
CEO
Jonathan Henderson, MD, is the CEO of Regional Urology, LLC in Shreveport, Louisiana. He received his MD at Louisiana State University Medical Center (LSUMC) in Shreveport, and he completed his internship and residency in urology at LSUMC Hospital. Dr Henderson spent the following 6 years in practice in Alabama, specializing in treating disorders of the female bladder and laparoscopy. During this time, he served as a representative of Alabama to the Southeastern Section of the American Urology Association, and was an assistant clinical professor of urology at the University of Alabama. Dr Henderson is a member of the American Urologic Association, Shreveport Medical Society, Louisiana State Medical Society, Society of Laparoscopic Surgeons, and the Alpha Omega Alpha Medical Honor Society.
